The balance sheet has strengthened materially, with the Debt-to-Equity ratio declining from 0.52 to 0.37 over the past year, driven by retained earnings growth that now constitutes 42% of total equity.
IBEX Limited (IBEX) balance sheet — 11-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jun'26 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 |
|---|
| Total Current Assets | 196.54M | 179.64M | 145.62M | 179.96M | 158.61M | 142.35M | 141.37M | 86.04M | 81.78M | 82M | 88.58M | 80.75M |
| Cash & Short-Term Investments | 36.7M | 32.57M | 15.35M | 62.72M | 57.43M | 48.83M | 57.84M | 21.87M | 8.87M | 13.52M | 21.32M | 9.45M |
| Cash Only | 36.7M | 32.57M | 15.35M | 62.72M | 57.43M | 48.83M | 57.84M | 21.87M | 8.87M | 13.52M | 21.32M | 9.45M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 136.29M | 129.52M | 118.7M | 107.64M | 92.37M | 75.43M | 72.61M | 57.94M | 64.12M | 60.35M | 63.85M | 65.89M |
| Days Sales Outstanding | 72.25 | 73.4 | 77.61 | 77.25 | 64.45 | 55.86 | 59.78 | 52.2 | 63.53 | 64.37 | 69.77 | 74.45 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 505K | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | 0.67 | - |
| Other Current Assets | 23.55M | 17.55M | 2.13M | 1.89M | 2.19M | 10.95M | 673K | 0 | 0 | 2.62M | 3.26M | 5.41M |
| Total Non-Current Assets | 136.03M | 129.5M | 127.6M | 113.95M | 134.72M | 151.83M | 132.91M | 109.2M | 106.53M | 75.08M | 63.65M | 57.69M |
| Property, Plant & Equipment | 102.29M | 96.22M | 94.84M | 89.01M | 112.07M | 125.03M | 106.7M | 84.59M | 82.31M | 18.9M | 22.81M | 23.33M |
| Fixed Asset Turnover | 6.74x | 6.69x | 5.89x | 5.71x | 4.67x | 3.94x | 4.16x | 4.79x | 4.48x | 18.11x | 14.64x | 13.84x |
| Goodwill | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.83M | 11.89M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 700K | 3.21M | 2.78M | 2.93M | 4.18M | 5.97M | 9.13M |
| Long-Term Investments | 859K | 413K | 0 | 0 | 0 | 382K | 258K | 2.94M | 227K | 392K | 294K | 288K |
| Other Non-Current Assets | 15.01M | 13.86M | 13.76M | 8.82M | 6.23M | 4.61M | 6.66M | 4.83M | 6.71M | 34.56M | 18.35M | 9.74M |
| Total Assets | 332.56M | 309.13M | 273.21M | 293.9M | 293.32M | 294.18M | 274.29M | 195.24M | 188.3M | 157.08M | 152.23M | 138.44M |
| Asset Turnover | 2.16x | 2.08x | 2.04x | 1.73x | 1.78x | 1.68x | 1.62x | 2.08x | 1.96x | 2.18x | 2.19x | 2.33x |
| Asset Growth % | 47.05% | 13.15% | -7.04% | 0.2% | -0.29% | 7.25% | 40.49% | 3.68% | 19.88% | 3.19% | 9.96% | - |
| Total Current Liabilities | 96.91M | 85.54M | 79.94M | 71M | 73.26M | 97.77M | 105.72M | 105.65M | 111.38M | 116.23M | 99.89M | 99.39M |
| Accounts Payable | 0 | 23M | 18.69M | 16.72M | 18.7M | 20.3M | 5.98M | 10.35M | 9.93M | 13.15M | 13.69M | 11.18M |
| Days Payables Outstanding | 18.04 | 18.4 | 17.69 | 17.12 | 18.21 | 19.82 | 6.51 | 13.68 | 14.23 | 18.98 | 18.09 | 15.66 |
| Short-Term Debt | 15.24M | 0 | 0 | 660K | 413K | 28.89M | 26.72M | 40.14M | 41.84M | 51.18M | 43.3M | 46.55M |
| Deferred Revenue (Current) | 29.71M | 6.38M | 5.5M | 4.75M | 6.41M | 8.6M | 4.08M | 3.47M | 4.39M | 5.66M | 4.92M | 8.17M |
| Other Current Liabilities | 73.69M | 0 | 0 | 0 | 0 | 3.56M | 35.83M | 18.59M | 19.07M | 21.9M | 1M | 0 |
| Current Ratio | 2.03x | 2.10x | 1.82x | 2.53x | 2.16x | 1.46x | 1.34x | 0.81x | 0.73x | 0.71x | 0.89x | 0.81x |
| Quick Ratio | 2.03x | 2.10x | 1.82x | 2.53x | 2.16x | 1.46x | 1.34x | 0.81x | 0.73x | 0.71x | 0.88x | 0.81x |
| Cash Conversion Cycle | 54.21 | - | - | - | - | - | - | - | - | - | 52.34 | - |
| Total Non-Current Liabilities | 54.11M | 53.37M | 58.97M | 57.11M | 70.1M | 82.95M | 87.91M | 73.43M | 68.29M | 12.89M | 23.61M | 19.3M |
| Long-Term Debt | 48.58M | 0 | 0 | 867K | 600K | 339K | 1.8M | 3.78M | 7.18M | 9.01M | 14.65M | 12.21M |
| Capital Lease Obligations | 142.33M | 47.63M | 54.6M | 53.44M | 64.85M | 76.32M | 71.88M | 62.04M | 58.6M | 866K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 86K | 117K | 147K | 61.29M | 5.34M | 4.62M |
| Other Non-Current Liabilities | 5.52M | 3.67M | 3.23M | 1.67M | 3.26M | 2.3M | 11.14M | 7.06M | 1.61M | 2.31M | 1.11M | 1.09M |
| Total Liabilities | 151.01M | 138.91M | 138.91M | 128.1M | 143.36M | 180.72M | 193.63M | 179.09M | 179.67M | 129.13M | 123.49M | 118.69M |
| Total Debt | 63.83M | 62.44M | 69.75M | 67.02M | 78.9M | 105.54M | 112.52M | 105.97M | 118.25M | 62.96M | 57.95M | 58.75M |
| Net Debt | 27.13M | 29.88M | 54.41M | 4.3M | 21.47M | 56.71M | 54.67M | 84.1M | 109.38M | 49.44M | 36.63M | 49.3M |
| Debt / Equity | 0.35x | 0.37x | 0.52x | 0.40x | 0.53x | 0.93x | 1.39x | 6.56x | 13.71x | 1.31x | 1.19x | 2.98x |
| Debt / EBITDA | 0.80x | 0.83x | 1.09x | 1.14x | 1.33x | 2.73x | 3.61x | 2.41x | 4.13x | - | 5.04x | 2.77x |
| Net Debt / EBITDA | 0.34x | 0.40x | 0.85x | 0.07x | 0.36x | 1.46x | 1.75x | 1.91x | 3.82x | - | 3.18x | 2.32x |
| Interest Coverage | 572.83x | 61.18x | 29.11x | 80.74x | 51.92x | 16.03x | 2.68x | 2.01x | 0.94x | -9.68x | -0.65x | 1.93x |
| Total Equity | 181.55M | 170.23M | 134.31M | 165.8M | 149.96M | 113.46M | 80.66M | 16.15M | 8.63M | 47.95M | 48.74M | 19.75M |
| Equity Growth % | 124.46% | 26.75% | -18.99% | 10.56% | 32.17% | 40.66% | 399.5% | 87.16% | -82.01% | -1.61% | 146.81% | - |
| Book Value per Share | 12.11 | 11.50 | 8.54 | 9.08 | 7.94 | 6.06 | 4.39 | 0.91 | 0.49 | 2.71 | 2.75 | 1.12 |
| Total Shareholders' Equity | 181.55M | 170.23M | 134.31M | 165.8M | 149.96M | 113.46M | 80.66M | 16.15M | 8.63M | 27.95M | 28.74M | 16.1M |
| Common Stock | 2K | 2K | 1K | 2K | 2K | 2K | 2K | 12K | 12K | 12K | 1K | 1K |
| Retained Earnings | 86.85M | 72.07M | 25.74M | -11.12M | -44.78M | -76.36M | -110.68M | -109.53M | -117.18M | -126.06M | -110.03M | -70.44M |
| Treasury Stock | 0 | -117.7M | -103.34M | -25.37M | -3.68M | -3.41M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -12.02M | -11.49M | -6.34M | -7.91M | -6.31M | 5.79M | 33.18M | 29.46M | 29.59M | 37.8M | 22.55M | 22.34M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M | 20M | 3.64M |
Quick answers to the most common questions about buying IBEX stock.
As of 2026, IBEX Limited (IBEX) had total assets of $309.1M including $179.6M in current assets.
IBEX Limited (IBEX) carries total debt of $62.4M, offset by $32.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
IBEX Limited (IBEX) has total shareholders' equity (book value) of $170.2M ($11.50 book value per share). Book value represents the net worth of the company belonging to common stock holders.
IBEX Limited (IBEX) reported a current ratio of 2.10x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Volatile cash generation from working capital
Metrics are mathematically derived from official filings.
Leverage Reduction Drives Strengthening Trajectory
IBEX's balance sheet has strengthened materially over the past year, with equity expanding by 26% from $134.3M in Q4 2025 to $170.2M in Q4 2026, primarily fueled by consistent retained earnings accumulation that has lowered its D/E ratio from 0.52 to 0.37.
The improvement in leverage is driven by internal profit generation rather than asset sales or equity issuances, which suggests a more sustainable strengthening path. However, this positive trajectory occurs alongside prior cash flow analysis findings of volatile cash conversion, indicating that the accounting profits funding equity growth may not be translating reliably into tangible liquidity buffers.
Strategic Deleveraging Amid Rising Asset Base
Total debt has been pruned by over $29M from its peak in Q2 2025 to $62.4M by Q4 2026, resulting in a conservative Debt/Assets ratio of just 20% and a D/E ratio of 0.37, as reported in recent SEC filings.
This reduction appears strategic, as it coincides with asset growth, suggesting management is using profits to optimize the capital structure rather than fund operations. The modest leverage level, well below peers like TTEC (D/E 8.86) and CNXC (D/E 1.69), implies limited refinancing risk and positions the company to weather potential operational downturns, though it may also indicate a cautious approach to leveraging growth opportunities.
Cash Position Volatile Despite Strong Coverage
While the current ratio improved to 2.10 in Q4 2026, IBEX's cash position remains volatile, ending Q4 2026 at $32.6M after fluctuating between $13.0M and $62.7M over the past ten quarters.
The strong current ratio provides a theoretical buffer against short-term obligations, but the significant quarter-to-quarter swings in the cash balance—such as the jump from $15.4M in Q3 2026 to $32.6M in Q4—align with prior findings of working capital-driven cash flow volatility. This suggests the company's liquidity is highly sensitive to timing of collections and payments, which warrants close monitoring for any sustained deterioration.
Retained Earnings Fuel Equity Quality
Retained earnings have surged from a negative $21.0M in Q3 2024 to a positive $72.1M by Q4 2026, representing 42% of total equity and serving as the primary engine for balance sheet strengthening.
This rapid turnaround in retained earnings indicates that the recent profitability, while strained at the margin level, is sufficient to rebuild the company's equity base after prior losses. The reliance on internal generation, rather than share issuances, is a positive for equity quality, though it also means the pace of strengthening is directly tied to the sustainability of the ongoing margin pressures noted in the income statement analysis.
Goodwill and Deferred Revenue Mask Asset Risks
The $11.8M of goodwill, unchanged for ten quarters, and the fluctuating deferred revenue balance (from $4.9M to $10.0M) suggest potential overstatement of asset quality and revenue visibility not captured by headline liquidity ratios.
Goodwill, representing 3.8% of total assets, is a non-cash asset that could be subject to impairment if business performance weakens, yet its static nature raises questions about the rigor of ongoing impairment testing. Concurrently, the variability in deferred revenue, which peaked at $10.0M in Q2 2026 before falling to $8.5M, adds uncertainty to the predictability of future revenue streams and cash inflows, a nuance that the strong current ratio does not reflect.